Invasive Fungal Infections Surveillance Initiative
| Status: | Completed |
|---|---|
| Conditions: | Infectious Disease |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 11/18/2012 |
| Start Date: | August 2005 |
| End Date: | December 2015 |
| Contact: | David Paterson, MD |
| Email: | patersond@dom.pitt.edu |
| Phone: | 412-648-6401 |
The purpose of this study is to optimize the management of patients treated for IFIs
(invasive fungal infections) by establishing a real-time, continuous clinical data base that
will capture and monitor trends in the epidemiology, diagnosis, treatment and outcomes of
IFIs; reflect routine clinical management of patients with IFIs in order to evaluate
treatment and provide a rationale for future treatment paradigms; and allow physicians to
assess adherence to institutional clinical practice guidelines, validate current
standardized definitions for patients with IFIs and promote change where appropriate.
Gender, height, weight, ethnicity, antifungal treatment, fungal colonization, laboratory
results, past medical history, IFI diagnosis, medications, outcomes
Inclusion Criteria:
- All patients with a diagnosis of proven or probable IFI. This includes patients with
proven or probable invasive mold infections as well as patients with proven
candidemia.
Exclusion Criteria:
- All patients with a diagnosis of possible IFI. This includes patients with possible
mold infections as well as patients with possible candidemia.
We found this trial at
1
site
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
Click here to add this to my saved trials
